Portland-based Covetrus reconfigures its international leadership

The retirement of two senior executives at Covetrus Inc. (Nasdaq: CVET) is prompting the Portland-based animal health company to change up leadership of its geographic markets.

András Bolcskei has joined Covetrus as president of the company’s International business unit, a newly created position that combines the presidential roles for Europe and for Asia-Pacific and emerging markets. Those positions were held respectively by Mike Ellis and David Hinton, who are retiring, a news release Monday said.

Bolcskei has more than 25 years of experience and a background in animal health pharmaceuticals, including at both Merck & Co. and Pfizer, where he held leadership roles across Europe and Africa. He is also a veterinarian. Read more

Related Posts

Bar Harbor approves Jackson Lab’s $33M expansion for rare disease research

The Bar Harbor Planning Board has approved a plan by the Jackson Laboratory to build a 20,000-square-foot expansion to its Rare Disease Translational...

22 August 2024

Bigelow lab receives $7 million for algae research, business development

Researchers at Bigelow Laboratory for Ocean Sciences believe algae can make a big splash in the agricultural, aquaculture and pharmaceutical industries,...

21 August 2024

Should Maine create a public medical school? UMaine System will study the question

The University of Maine System said this week it will work with a national consultant to study the feasibility of launching the state’s...

21 August 2024